These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances. Ahmed RZ; Patil G; Zaheer Z Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585 [TBL] [Abstract][Full Text] [Related]
3. Nanosuspensions: a promising drug delivery strategy. Patravale VB; Date AA; Kulkarni RM J Pharm Pharmacol; 2004 Jul; 56(7):827-40. PubMed ID: 15233860 [TBL] [Abstract][Full Text] [Related]
4. Has nanotechnology led to improved therapeutic outcomes? Bosselmann S; Williams RO Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583 [TBL] [Abstract][Full Text] [Related]
6. Themed issue: improve dissolution, solubility and bioavailability of poorly soluble drugs. Perrie Y; Rades T J Pharm Pharmacol; 2010 Nov; 62(11):1517-8. PubMed ID: 21039536 [No Abstract] [Full Text] [Related]
7. [The research progress of preparation methods of solid nanocrystal delivery system]. Yue PF; Wang Y; Wan J; Wu ZF; Hu PY; Zheng Q; Yuan HL; Yang M Yao Xue Xue Bao; 2012 Sep; 47(9):1120-7. PubMed ID: 23227539 [TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for oral drug delivery. Zhang L; Wang S; Zhang M; Sun J J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127 [TBL] [Abstract][Full Text] [Related]
9. Nanostructure-mediated drug delivery. Hughes GA Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054 [TBL] [Abstract][Full Text] [Related]
10. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. GuhaSarkar S; Banerjee R J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo testing methods for respiratory drug delivery. Agu RU; Ugwoke MI Expert Opin Drug Deliv; 2011 Jan; 8(1):57-69. PubMed ID: 21174605 [TBL] [Abstract][Full Text] [Related]
12. Nanotechnology controlled drug delivery for treating bone diseases. Yang L; Webster TJ Expert Opin Drug Deliv; 2009 Aug; 6(8):851-64. PubMed ID: 19637973 [TBL] [Abstract][Full Text] [Related]
13. Ordered mesoporous silicates as matrices for controlled release of drugs. Ukmar T; Planinšek O Acta Pharm; 2010 Dec; 60(4):373-85. PubMed ID: 21169131 [TBL] [Abstract][Full Text] [Related]
14. Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices. Veiga F; Salsa T; Pina ME Drug Dev Ind Pharm; 1998 Jan; 24(1):1-9. PubMed ID: 15605591 [TBL] [Abstract][Full Text] [Related]
15. Role of nanotechnology in developing new therapies for diseases of the nervous system. Jain KK Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203 [No Abstract] [Full Text] [Related]
16. A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets. Conte U; Maggi L J Control Release; 2000 Feb; 64(1-3):263-8. PubMed ID: 10640662 [No Abstract] [Full Text] [Related]
17. Advances and challenges of nanotechnology-based drug delivery systems. Jiang W; Kim BY; Rutka JT; Chan WC Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665 [TBL] [Abstract][Full Text] [Related]
18. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Brough C; Williams RO Int J Pharm; 2013 Aug; 453(1):157-66. PubMed ID: 23751341 [TBL] [Abstract][Full Text] [Related]
19. The rise and rise of drug delivery. Rosen H; Abribat T Nat Rev Drug Discov; 2005 May; 4(5):381-5. PubMed ID: 15864267 [TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticles for the delivery of poorly water-soluble drugs. Bunjes H J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]